UK:
Vaccine Research Relief
To print this article, all you need is to be registered or login on Mondaq.com.
The measure
Vaccine research relief (VRR) for SMEs will be reduced from 40%
to 20% from 1 April 2011 and will no longer be available to them
from 1 April 2012.
Who will be affected?
This will affect SMEs who currently claim VRR on qualifying
costs relating to research and development of certain vaccines or
medicines. Relief will continue to be available for large
companies.
When?
VRR will be reduced to 20% from 1 April 2011. SMEs will not be
able to claim VRR from 1 April 2012.
Our view
A very limited number of SMEs actually claim VRR. As a result,
the removal of the relief for SMEs should not significantly affect
business.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Tax from UK
All Change For Non-doms
Lubbock Fine
Although there had been speculation in the run up to the Spring Budget that the Chancellor was set to steal Labour's proposals to 'abolish non-dom status', the actual announcements from Jeremy Hunt...
Tax – A Shake-Up Looms
Herbert Smith Freehills
Few developments in the tax world have an impact on a truly global scale, but the so-called 'Pillar Two' rules – essentially a global minimum corporate tax – is one of them.
UK Tax Round Up
Proskauer Rose LLP
Welcome to March's edition of our UK Tax Round Up. This month has seen a number of interesting cases covering a range of issues, from the deductibility of costs against employment income...
